Investor Relations

NEXT GENERATION SOLUTIONS

AbGenomics group is developing first-in-class drugs and novel best-in-class therapeutics for inflammatory/autoimmune diseases and cancers.

Financial Information

View a full library of AbGenomics’ financial report

more

Stock Information

more

Governance

Sound principles of corporate governance are crucial to our success. The Audit Committee and Compensation Committee under the board of directors ensures that AbGenomics Holding Ltd. holds to these principles and earns the trust of both its shareholders and employees.

more

Corporate Social Responsibility

We are passionate about helping patients. From day one of our founding, we at AbGenomics have taken a pioneering approach to develop innovative therapies for unmet medical needs. We work tirelessly toward a healthier future.

IR Contact

Contact Us